Zoxitin

Zoxitin

Ointment, 400 mg/g

Each gram of ointment contains: zinc oxide 400 mg.

Excipients with known effect: anhydrous lanolin 65 mg/g, methylparahydroxybenzoate (E218) 0.8 mg/g, butylhydroxyanisole (E320).

Other excipients: cod liver oil, white soft paraffin, talc, lemon oil, purified water.

A dermatological medicine with emollient and protective action. Indicated for: nappy rash (prevention and treatment), intertrigo, miliaria, superficial wounds, burns, dermatitis, ulcerative skin conditions.

Zinc oxide has local anti-inflammatory, antiseptic, astringent and adsorbent action. It forms a protective layer on the skin surface, reduces inflammation and accelerates healing. Cod liver oil and lanolin soften the skin and promote tissue regeneration. It is practically not absorbed into the systemic circulation.

Apply externally. Clean and dry the affected area first. Apply a thin layer of ointment to the affected skin areas 2–3 times daily. For burns and wounds, apply as a dressing with ointment. For prevention of intertrigo, apply to areas subject to prolonged contact and friction.

hypersensitivity to zinc oxide or to any of the excipients;

acute purulent inflammatory conditions of the skin and adjacent tissues.

Important to know

For external use only. Avoid contact with eyes. The ointment contains anhydrous lanolin which may cause local skin reactions (contact dermatitis), and methylparahydroxybenzoate (E218) and butylhydroxyanisole (E320) which may cause allergic reactions. Use during pregnancy and breast-feeding is permitted. Read the package leaflet carefully before use.

Possible side effects

Very rare: allergic contact skin reactions — itching, erythema, skin rash. If side effects occur, stop use and consult your doctor.

Store below 25 °C. Keep out of the reach of children. Shelf life: 36 months.

Aluminium tube of 40 g ointment with package leaflet in a carton box.

For questions about this medicine, please consult your doctor or pharmacist. Manufacturer: FARMAPRIM SRL, 5 Crinilor str., Porumbeni village, Criuleni district, Republic of Moldova, MD-4829. Pharmacovigilance: safety@farmaprim.md.

Brief information prepared on the basis of the approved Summary of Product Characteristics. It does not replace consultation with a doctor or pharmacist and does not contain all information about the medicine. Always read the package leaflet.